Skip to content
Screener

Lucid Diagnostics LUCD Book value per share

Book value per share at other companies

Castle Biosciences logo
Castle BiosciencesCSTL
$15.44+0.3%
Guardant Health logo
Guardant HealthGH
-$1.38+31.9%
Insight Molecular Diagnostics Inc. logo
Insight Molecular Diagnostics Inc.IMDX
-$0.58-1,790%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$0.89+472%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$34.00-7.0%
Personalis, Inc. logo
Personalis, Inc.PSNL
$2.45+3.1%

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$184.5M+70.9%
Enterprise value$158.22M+100%
P/S35.9×+11.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Calculated from Lucid Diagnostics’s reported figures.

Based on the most recent quarter.

The source filing: Lucid Diagnostics’s 10-Q, filed November 12, 2025. Open the filing →

Filed
Nov 12, 2025
Fiscal quarter
Q3 FY2025
Calendar quarter
Q3 2025
Accession
0001493152-25-021737

FAQ

What is Lucid Diagnostics's book value per share?
Lucid Diagnostics (LUCD) reported book value per share of $0.24 in Q3 2025.
How has Lucid Diagnostics's book value per share changed year-over-year?
Lucid Diagnostics's book value per share increased by 89.8% year-over-year, from $0.13 to $0.24.
What is the long-term trend for Lucid Diagnostics's book value per share?
Over 4 years (2020 to 2024), Lucid Diagnostics's book value per share has grown at a -42.2% compound annual growth rate (CAGR), from -$0.96 to $0.11.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ask your AI about Lucid Diagnostics's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude